Synthesis in Medicinal Chemistry
Authors:
- 3 February 2023
- book chapter
- Published by Royal Society of Chemistry (RSC)
- p. 40-93
Abstract
The discovery, optimisation and manufacture of medicines are processes underpinned by synthesis on scales from milligrams to tonnes; synthetic or semi-synthetic pharmaceuticals remain the cornerstones of modern medicines, as chemists innovate to deliver molecules to address contemporary challenges. This chapter reviews the crucial impact of synthesis, considering changing practices, contemporary developments in technology and methodology, and provides a view to how things may develop in future.Keywords
This publication has 139 references indexed in Scilit:
- How Are Fragments Optimized? A Retrospective Analysis of 145 Fragment OptimizationsJournal of Medicinal Chemistry, 2013
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing plateletsNature Medicine, 2013
- Natural-product-derived fragments for fragment-based ligand discoveryNature Chemistry, 2012
- Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticityDrug Discovery Today, 2011
- Synopsis of Some Recent Tactical Application of Bioisosteres in Drug DesignJournal of Medicinal Chemistry, 2011
- Factors Determining the Selection of Organic Reactions by Medicinal Chemists and the Use of These Reactions in Arrays (Small Focused Libraries)Angewandte Chemie International Edition, 2010
- Bioreactor engineering for recombinant protein production in plant cell suspension culturesBiochemical Engineering Journal, 2009
- Attempts To Improve the Overall Stereoselectivity of the Ireland−Claisen RearrangementOrganic Letters, 2008
- Leveraging the Advantages Offered by Microfluidics to Enhance the Drug Discovery ProcessQSAR & Combinatorial Science, 2005
- Creating a machine language for organic chemistryInformation Storage and Retrieval, 1963